Dript IV Therapy and IVRS, two leading providers of IV hydration and nutritional supplement therapy to nursing home residents, have merged, creating the sector’s largest IV hydration and nutritional...
FDA allows injections, reduced dose of COVID monoclonal antibody therapy
By
Alicia Lasek
Jun 08, 2021
An effective but arguably underused COVID-19 monoclonal antibody therapy now may be more accessible for long-term care facilities that aren’t equipped to deliver intravenous infusions.
Bamlanivimab cuts risk of COVID in nursing homes and assisted living, study finds
By
Alicia Lasek
Jun 08, 2021
The investigation was conducted before the FDA revoked emergency use of the drug — a monoclonal antibody — due to the impact of genetic variants on efficacy. But it still can be used in combination...
HHS halts Eli Lilly’s single-drug COVID antibody treatment in U.S.; dual-drug alternative remains in...
By
Alicia Lasek
Mar 26, 2021
U.S. distribution of an infusion treatment using bamlanivimab only has been halted due to virus variant concerns, but an alternative antibody cocktail from the drugmaker can still be ordered, according...
Feds authorize combo antibody infusion to treat COVID-19 in older adults with chronic disease
By
Alicia Lasek
Feb 11, 2021
The latest Eli Lilly therapy has received emergency approval for treating mild to moderate COVID-19 in patients at high risk for progressing to severe disease and/or hospitalization. This includes adults...
New ‘weapon in our arsenal’: Antibody drug cuts COVID risk by 80 percent in LTC residents
By
Alicia Lasek
Jan 22, 2021
Staff and residents who received Eli Lilly’s monoclonal antibody therapy were less likely to contract symptomatic COVID-19 than placebo groups in a late-stage trial. Industry advocates are hailing...
AMDA to feds: Delay antibody treatment in nursing homes, engage LTC medical directors
By
Alicia Lasek
Nov 09, 2020
“This is the right therapy, but it needs more study … and it needs engaged medical director oversight and supervision,” says AMDA’s Executive Director Chris Laxton. Emergency approval of COVID...
Shore Capital sells infusion therapy company
Dec 03, 2013
Shore Capital Partners, a private equity firm, has sold its home infusion therapy portfolio company, SCP Specialty Infusion, to AxelaCare Health Solutions.